Treatment Options for Ulcerative Colitis

Trampvia, also known as guselcomab, is an effective prescription treatment for adults with moderately to severely active ulcerative colitis (UC). Many patients have experienced significant improvements, with a notable number achieving clinical and endoscopic remission after one year of treatment. However, individual results can vary widely, necessitating a personalized approach to management. Patients are advised to consult their doctor about their symptoms and suitability for Trampvia, taking into consideration potential risks such as serious allergic reactions and the increased likelihood of infections.